首页> 美国卫生研究院文献>Future Science OA >Development of thrombocytopenia is associated with improved survival in patients treated with immunotherapy

【2h】

Development of thrombocytopenia is associated with improved survival in patients treated with immunotherapy

机译：血小板减少症的发展与免疫疗法治疗的患者的提高生存相关

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Immune-related adverse events are associated with efficacy of immune checkpoint inhibitors (ICIs). We hypothesize that immune-mediated thrombocytopenia could be a biomarker for response to ICIs.

机译：免疫相关不良事件与免疫检查点抑制剂（ICIS）的功效有关。我们假设免疫介导的血小板减少症可以是酸冰的生物标志物。

著录项

期刊名称 Future Science OA
作者
Hussein A Assi; Adam S Asch; Michael Machiorlatti; Sara K Vesely; Sami Ibrahimi;
展开▼
作者单位

展开▼
年(卷),期 2020(6),7
年度 2020
页码 -1
总页数 8
原文格式 PDF
正文语种
中图分类情报学;
关键词
checkpoint inhibitors; immune-mediated; immunotherapy; PD1/PDL-1 inhibitors; platelets; prognosis; survival; thrombocytopenia;

相似文献

外文文献
中文文献
专利

1. Development of thrombocytopenia is associated with improved survival in patients treated with immunotherapy [J] . Hussein A Assi, Adam S Asch, Michael Machiorlatti, Future Science OA . 2020,第7期

机译：血小板减少症的发展与免疫疗法治疗的患者的提高生存相关
2. Use of cytokines in cancer vaccines/immunotherapy: recent developments improve survival rates for patients with metastatic malignancy. [J] . Dezfouli S, Hatzinisiriou I, Ralph SJ Current pharmaceutical design . 2005,第27期

机译：细胞因子在癌症疫苗/免疫治疗中的应用：最新进展提高了转移性恶性肿瘤患者的生存率。
3. Use of Cytokines in Cancer Vaccines/Immunotherapy: Recent Developments Improve Survival Rates for Patients with Metastatic Malignancy [J] . S. Dezfouli I. Hatzinisiriou S. J. Ralph Current Pharmaceutical Design . 2005,第27期

机译：细胞因子在癌症疫苗/免疫治疗中的应用：最新进展提高了转移性恶性肿瘤患者的生存率
4. Delta-Radiomics Signature For Prediction Of Survival In Advanced Nsclc Patients Treated With Immunotherapy [C] . B. Farina, A. D. Ramos Guerra, C. Palacios Miras, IEEE International Symposium on Biomedical Imaging . 2021

机译：用于预测免疫疗法治疗的高级NSCLC患者存活的三角洲 - 辐射瘤
5. Emergency Responders’ Study: Making a Case for Organization Development on Improving the Process for Identifying and Treating Stroke Patients in the Field [D] . Dombrowski, Karen F. 2021

机译：紧急响应者的研究：为改善域中脑卒中患者的改进过程进行组织开发案例
6. Immunotherapy in Metastatic Colorectal Cancer: Could the Latest Developments Hold the Key to Improving Patient Survival? [O] . Emmanouil Damilakis, Dimitrios Mavroudis, Maria Sfakianaki, 2020

机译：转移性结直肠癌的免疫治疗：最新进展能否把握住提高患者生存率的关键？
7. Development of thrombocytopenia is associated with improved survival in patients treated with immunotherapy [O] . Hussein A Assi, Adam S Asch, Michael Machiorlatti, 2020

机译：血小板减少症的发展与免疫疗法治疗的患者的提高生存相关

Development of thrombocytopenia is associated with improved survival in patients treated with immunotherapy

摘要

著录项

相似文献

相关主题

期刊订阅